Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells

ConclusionsThese findings suggest that combining cisplatin with agents that target the RSK mediated cell survival pathway, may potentiate the cisplatin effect in lung adenocarcinoma.

Source: Journal of Pharmacy and Pharmacology - July 14, 2020 Category: Drugs & Pharmacology Authors: Nabeel Abdulrahman, Kodappully Sivaraman Siveen, Jensa Mariam Joseph, Aisha Osman, Huseyin C. Yalcin, Anwarul Hasan, Shahab Uddin, Fatima Mraiche Tags: Research Paper Source Type: research